Middle East Healthcare Company Statistics

Total Valuation

Middle East Healthcare Company has a market cap or net worth of SAR 6.35 billion. The enterprise value is 8.83 billion.

Market Cap	6.35B
Enterprise Value	8.83B

Important Dates

The last earnings date was Monday, November 4, 2024.

Earnings Date	Nov 4, 2024
Ex-Dividend Date	n/a

Share Statistics

Middle East Healthcare Company has 92.04 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	92.04M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.97%
Owned by Institutions (%)	3.99%
Float	40.81M

Valuation Ratios

The trailing PE ratio is 30.05 and the forward PE ratio is 22.82. Middle East Healthcare Company's PEG ratio is 0.74.

PE Ratio	30.05
Forward PE	22.82
PS Ratio	2.23
PB Ratio	3.74
P/TBV Ratio	3.84
P/FCF Ratio	30.90
P/OCF Ratio	n/a
PEG Ratio	0.74

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.97, with an EV/FCF ratio of 42.97.

EV / Earnings	41.79
EV / Sales	3.09
EV / EBITDA	13.97
EV / EBIT	20.71
EV / FCF	42.97

Financial Position

The company has a current ratio of 1.74, with a Debt / Equity ratio of 1.42.

Current Ratio	1.74
Quick Ratio	1.56
Debt / Equity	1.42
Debt / EBITDA	3.93
Debt / FCF	12.08
Interest Coverage	1.90

Financial Efficiency

Return on equity (ROE) is 12.80% and return on invested capital (ROIC) is 6.49%.

Return on Equity (ROE)	12.80%
Return on Assets (ROA)	5.25%
Return on Capital (ROIC)	6.49%
Revenue Per Employee	676,244
Profits Per Employee	50,085
Employee Count	4,220
Asset Turnover	0.56
Inventory Turnover	20.16

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.71% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-10.71%
50-Day Moving Average	70.72
200-Day Moving Average	84.77
Relative Strength Index (RSI)	46.41
Average Volume (20 Days)	200,058

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Middle East Healthcare Company had revenue of SAR 2.85 billion and earned 211.36 million in profits. Earnings per share was 2.30.

Revenue	2.85B
Gross Profit	1.12B
Operating Income	426.40M
Pretax Income	240.92M
Net Income	211.36M
EBITDA	614.61M
EBIT	426.40M
Earnings Per Share (EPS)	2.30

Full Income Statement

Balance Sheet

The company has 49.86 million in cash and 2.48 billion in debt, giving a net cash position of -2.43 billion or -26.45 per share.

Cash & Cash Equivalents	49.86M
Total Debt	2.48B
Net Cash	-2.43B
Net Cash Per Share	-26.45
Equity (Book Value)	1.75B
Book Value Per Share	18.46
Working Capital	948.23M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 664.83 million and capital expenditures -459.28 million, giving a free cash flow of 205.55 million.

Operating Cash Flow	664.83M
Capital Expenditures	-459.28M
Free Cash Flow	205.55M
FCF Per Share	2.23

Full Cash Flow Statement

Margins

Gross margin is 39.07%, with operating and profit margins of 14.94% and 7.41%.

Gross Margin	39.07%
Operating Margin	14.94%
Pretax Margin	8.44%
Profit Margin	7.41%
EBITDA Margin	21.54%
EBIT Margin	14.94%
FCF Margin	7.20%

Dividends & Yields

Middle East Healthcare Company does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	3.33%
FCF Yield	3.24%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Middle East Healthcare Company has an Altman Z-Score of 2.65. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.65
Piotroski F-Score	n/a